Cargando…
Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism
BACKGROUND: Alcoholic liver disease is caused as a result of chronic alcohol consumption. In this study, we used an alcoholic liver injury mouse model to investigate the effect of fucoidan on ethanol-induced liver injury and steatosis and the underlying mechanisms. METHODS: All mice were randomly di...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Academia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098649/ https://www.ncbi.nlm.nih.gov/pubmed/33994911 http://dx.doi.org/10.29219/fnr.v65.5384 |
_version_ | 1783688451851288576 |
---|---|
author | Xue, Meilan Liang, Hui Zhou, Zhitong Liu, Ying He, Xinjia Zhang, Zheng Sun, Ting Yang, Jia Qin, Yimin Qin, Kunpeng |
author_facet | Xue, Meilan Liang, Hui Zhou, Zhitong Liu, Ying He, Xinjia Zhang, Zheng Sun, Ting Yang, Jia Qin, Yimin Qin, Kunpeng |
author_sort | Xue, Meilan |
collection | PubMed |
description | BACKGROUND: Alcoholic liver disease is caused as a result of chronic alcohol consumption. In this study, we used an alcoholic liver injury mouse model to investigate the effect of fucoidan on ethanol-induced liver injury and steatosis and the underlying mechanisms. METHODS: All mice were randomly divided into four groups: 1) control group, 2) model group, 3) diammonium glycyrrhizinate treatment group (200 mg/kg body weight), and 4) fucoidan treatment group (300 mg/kg body weight). Administration of ethanol for 8 weeks induced liver injury and steatosis in mice. RESULTS: Fucoidan treatment decreased serum alanine aminotransferase activity, serum total cholesterol levels, and hepatic triglyceride levels, and improved the morphology of hepatic cells. Fucoidan treatment upregulated the expression of AMPKα1, SIRT1, and PGC-1α and inhibited the expression of ChREBP and HNF-1α. The levels of hepatic IL-6 and IL-18 were significantly decreased in the fucoidan group. Further, the levels of cytochrome P450-2E1 (CYP2E1), glucose-regulated protein (GRP) 78, and 3-nitrotyrosine (3-NT) in hepatic tissues were reduced in the fucoidan group as compared to the model group. Fucoidan significantly reversed the reduction of ileac Farnesoid X receptor (FXR) and fibroblast growth factor 15 (FGF15) levels induced by alcohol-feeding and reduced CYP7A1 (cholesterol 7α-hydroxylase) expression and total bile acid levels in the liver tissue. In addition, fucoidan regulated the structure of gut flora, with increased abundance of Prevotella and decreased abundance of Paraprevotella and Romboutsia as detected by 16S rDNA high-throughput sequencing. CONCLUSION: Fucoidan inhibited alcohol-induced steatosis and disorders of bile acid metabolism in mice through the AMPKα1/SIRT1 pathway and the gut microbiota–bile acid–liver axis and protected against alcohol-induced liver injury in vivo. |
format | Online Article Text |
id | pubmed-8098649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Open Academia |
record_format | MEDLINE/PubMed |
spelling | pubmed-80986492021-05-14 Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism Xue, Meilan Liang, Hui Zhou, Zhitong Liu, Ying He, Xinjia Zhang, Zheng Sun, Ting Yang, Jia Qin, Yimin Qin, Kunpeng Food Nutr Res Original Article BACKGROUND: Alcoholic liver disease is caused as a result of chronic alcohol consumption. In this study, we used an alcoholic liver injury mouse model to investigate the effect of fucoidan on ethanol-induced liver injury and steatosis and the underlying mechanisms. METHODS: All mice were randomly divided into four groups: 1) control group, 2) model group, 3) diammonium glycyrrhizinate treatment group (200 mg/kg body weight), and 4) fucoidan treatment group (300 mg/kg body weight). Administration of ethanol for 8 weeks induced liver injury and steatosis in mice. RESULTS: Fucoidan treatment decreased serum alanine aminotransferase activity, serum total cholesterol levels, and hepatic triglyceride levels, and improved the morphology of hepatic cells. Fucoidan treatment upregulated the expression of AMPKα1, SIRT1, and PGC-1α and inhibited the expression of ChREBP and HNF-1α. The levels of hepatic IL-6 and IL-18 were significantly decreased in the fucoidan group. Further, the levels of cytochrome P450-2E1 (CYP2E1), glucose-regulated protein (GRP) 78, and 3-nitrotyrosine (3-NT) in hepatic tissues were reduced in the fucoidan group as compared to the model group. Fucoidan significantly reversed the reduction of ileac Farnesoid X receptor (FXR) and fibroblast growth factor 15 (FGF15) levels induced by alcohol-feeding and reduced CYP7A1 (cholesterol 7α-hydroxylase) expression and total bile acid levels in the liver tissue. In addition, fucoidan regulated the structure of gut flora, with increased abundance of Prevotella and decreased abundance of Paraprevotella and Romboutsia as detected by 16S rDNA high-throughput sequencing. CONCLUSION: Fucoidan inhibited alcohol-induced steatosis and disorders of bile acid metabolism in mice through the AMPKα1/SIRT1 pathway and the gut microbiota–bile acid–liver axis and protected against alcohol-induced liver injury in vivo. Open Academia 2021-04-20 /pmc/articles/PMC8098649/ /pubmed/33994911 http://dx.doi.org/10.29219/fnr.v65.5384 Text en © 2021 Meilan Xue et al. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license. |
spellingShingle | Original Article Xue, Meilan Liang, Hui Zhou, Zhitong Liu, Ying He, Xinjia Zhang, Zheng Sun, Ting Yang, Jia Qin, Yimin Qin, Kunpeng Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism |
title | Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism |
title_full | Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism |
title_fullStr | Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism |
title_full_unstemmed | Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism |
title_short | Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism |
title_sort | effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098649/ https://www.ncbi.nlm.nih.gov/pubmed/33994911 http://dx.doi.org/10.29219/fnr.v65.5384 |
work_keys_str_mv | AT xuemeilan effectoffucoidanonethanolinducedliverinjuryandsteatosisinmiceandtheunderlyingmechanism AT lianghui effectoffucoidanonethanolinducedliverinjuryandsteatosisinmiceandtheunderlyingmechanism AT zhouzhitong effectoffucoidanonethanolinducedliverinjuryandsteatosisinmiceandtheunderlyingmechanism AT liuying effectoffucoidanonethanolinducedliverinjuryandsteatosisinmiceandtheunderlyingmechanism AT hexinjia effectoffucoidanonethanolinducedliverinjuryandsteatosisinmiceandtheunderlyingmechanism AT zhangzheng effectoffucoidanonethanolinducedliverinjuryandsteatosisinmiceandtheunderlyingmechanism AT sunting effectoffucoidanonethanolinducedliverinjuryandsteatosisinmiceandtheunderlyingmechanism AT yangjia effectoffucoidanonethanolinducedliverinjuryandsteatosisinmiceandtheunderlyingmechanism AT qinyimin effectoffucoidanonethanolinducedliverinjuryandsteatosisinmiceandtheunderlyingmechanism AT qinkunpeng effectoffucoidanonethanolinducedliverinjuryandsteatosisinmiceandtheunderlyingmechanism |